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Cancers are a heterogeneous mix of cells, some of which exhibit cancer stem cell-like characteristics including ATP-dependent drug
efflux and elevated tumorigenic potential. To determine whether aerodigestive squamous cell carcinomas (SCCs) contain a
subpopulation of cancer stem cell-like cells, we performed Hoechst dye efflux assays using four independent cell lines. Results
revealed the presence of a rare, drug effluxing stem cell-like side population (SP) of cells within all cell lines tested (SCC-SP cells).
These cells resembled previously characterised epithelial stem cells, and SCC-SP cell abundance was positively correlated with overall
cellular density and individual cell quiescence. Serial SCC-SP fractionation and passaging increased their relative abundance within the
total cell population. Purified SCC-SP cells also exhibited increased clonogenic potential in secondary cultures and enhanced
tumorigenicity in vivo. Despite this, SCC-SP cells remained chemotherapeutically sensitive upon ATP-dependent transporter
inhibition. Overall, these findings suggest that the existence of ATP transporter-dependent cancer stem-like cells may be relatively
common, particularly within established tumours. Future chemotherapeutic strategies should therefore consider coupling
identification and targeting of this potential stem cell-like population with standard treatment methodologies.
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Stem cells are present in many tissues where they function to
maintain appropriate homeostasis and differentiation as well as
regulate tissue responses to injury and infection (Watt and Hogan,
2000; Janes et al, 2002). These cells are capable of self-renewal,
have a relatively undifferentiated phenotype, exhibit high pro-
liferative potential, and are multipotent (Griffiths et al, 2005). In
adult tissues, stem cells tend to divide infrequently and many
exhibit an intrinsic resistance to environmental toxins or
chemotherapeutic agents (Giangreco et al, 2002; Zhou et al,
2002; Hirschmann-Jax et al, 2004).
Traditionally, stem cell pollutant resistance has been identified
on the basis of efficient Hoechst 33342 dye efflux (Goodell et al,
1996). Drug-resistant stem cells, termed side population (SP) cells,
have been identified in a growing number of tissues including bone
marrow, pancreas, muscle, brain, and lung (Goodell et al, 1996;
Lechner et al, 2002; Giangreco et al, 2003; Summer et al, 2003;
Kondo et al, 2004; Oyama et al, 2007). This SP phenotype is
dependent on ATP-binding cassette (ABC) transporter activity, as
ATP inhibitors such as verapamil and reserpine block dye efflux
(Goodell et al, 1997; Zhou et al, 2001; Scharenberg et al, 2002). In
particular, the ABC transporter ABCG2/BCRP1 appears critical to
maintain this phenotype as Abcg2 knockout mice lack SP cells and
are particularly sensitive to chemotherapeutic agents such as
mitoxantrone (Zhou et al, 2002).
In addition to normal tissues, recent evidence suggests that
some cancers also contain a population of stem-like, pollutant-
resistant cells (Passegue et al, 2003). Cancer stem or stem-like cells,
which exhibit increased chemotherapeutic drug resistance, have
been found within acute myeloid leukaemia (Wulf et al, 2001; Reya
et al, 2003), breast, and brain solid tumours (Al-Hajj et al, 2003).
Recently, several cancer cell lines have been identified that contain
a subpopulation of chemotherapeutic-resistant, cancer SP cells
including the rat glioma line C6, human breast cancer line MCF-7,
rat neuroblastoma line B104, and the human adenocarcinoma cell
line HeLa (Kondo et al, 2004). Cancer SP cells have also been
identified in vivo within 65% of human neuroblastoma tumours
(Hirschmann-Jax et al, 2004). These repopulate both SP and non-
SP cell types, indicating their multipotent differentiation potential
(Hirschmann-Jax et al, 2004). They also express numerous ABC
transporter proteins, providing them with increased drug resis-
tance (Hirschmann-Jax et al, 2004). Finally, it appears that
following chemotherapy, cancer SP are uniquely capable of
producing drug-insensitive secondary tumours (Passegue et al,
2003). On the basis of these observations, cancer SP cells are
increasingly considered to be potential cancer stem cells (Hadnagy
et al, 2006; Giangreco et al, 2006).
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sAerodigestive squamous cell carcinomas (SCCs) frequently
exhibit chemotherapeutic resistance and increased metastatic
potential following unsuccessful cancer treatment. We, therefore,
wished to determine whether SCC cell lines contained SP cells, and,
if so, whether these displayed cancer stem cell characteristics. We
now describe the presence of an SCC-SP cell subset whose
abundance was positively correlated with increasing cell con-
fluence and quiescence. These cells exhibited characteristics of
cancer stem cells including increased growth, multipotent
differentiation, and a capacity for in vivo tumorigenesis.
MATERIALS AND METHODS
Tissue culture
H357, SCC4, SCC13, and SCC15 cell lines, derived from patients
with advanced SCCs, were cultured in complete FAD medium
(Sugiyama et al, 1993). The culture medium (FADþFCSþHICE)
consisted of one part Ham’s F12 medium and three parts
Dulbecco’s modified Eagle’s medium, supplemented with 10%
fetal calf serum (FCS), 0.5mgml
 1 hydrocortisone, 5mgml
 1
insulin, 10
 10 M cholera toxin, and 10ngml
 1 epidermal growth
factor (HICE). The culture medium was changed every 2 days.
Fluorescence-activated cell sorting
Cells were harvested at 70% or full confluence, washed, and
resuspended at 1 10
6 cellsml
 1 in FAD medium and incubated at
371C for 10min. Cells were labelled with 5mM Hoechst 33342
(Sigma, St Louis, MI) for 15, 30, 45, 60, 75, 90, 105, 120, and
135min at 371C to determine the required incubation time. As the
size of the SP was found to be stable from 30min, all subsequent
staining was carried out for 45min at 371C. The cells were
counterstained with 5mgml
 1 propidium iodide (Sigma) to label
dead cells, which were excluded from the analysis. Fluorescence-
activated cell sorting (FACS) was performed using a MoFlo High-
Performance Cell Sorter (DakoCytomation, Denmark). For SP
analysis, at least 1 10
5 total events were collected, and all
subsequent analysis was performed using FlowJo software (Tree
Star Inc., Ashland, Oregon). For cell cycle status analysis following
Hoechst 33342 efflux, ethanol-fixed cells were stained with
50mgml
 1 propidium iodide in the presence of RNase A
(50mgml
 1) and analysed with a FACS-Calibur flow cytometer.
The Watson Pragmatic model was applied to determine cell cycle.
All flow cytometry experiments were repeated to confirm
consistency. A representative plot is shown for each profile.
Colony-forming assays
In all, 200 SP and non-SP H357 cells were seeded per six-well plate
and cultured for 14 days. Colonies were washed, fixed using 3%
paraformaldehyde (BDH), and stained with Rhodanile Blue
overnight. Colonies of two or more cells were counted using an
Olympus CK2 inverted phase-contrast light microscope. Abortive
colonies were defined as colonies that contained fewer than 32 cells
according to the system described by Jones and Watt (1993). A
large colony was defined as greater than 32 cells per colony. All
experiments were performed in triplicate. In mitoxantrone
dihydrochloride (Sigma) dose–response assays, 200 H357 cells
were plated per well of a six-well plate and cultured in the presence
of 0, 1, or 10ngml
 1 of mitoxantrone for 3 days. After a further 14
days, the cultures were fixed, stained, and counted. In mitoxan-
trone and verapamil assays, 300 H357 cells were plated per well of
a six-well plate, cultured in the presence of 0, 1, or 10ngml
 1 of
mitoxantrone±verapamil hydrochloride 100mM (Sigma) for 7
days, and, subsequently, grown for a further 7 days in the absence
of drugs.
Proliferation assay
A total of 1000 H357 cells were plated per well and cultured in
complete FAD medium. Cells were harvested at days 2, 4, and 8,
and cell number counted by haemocytometer. Each H357 cell
population and time point were analysed in triplicate.
Quantitative RT-PCR
cDNA synthesis (random hexamersþSuperscript II; Invitrogen,
Paisley, UK) and subsequent quantitative RT-PCR (QPCR) was
performed using 1mg of total RNA isolated from freshly sorted or
serially passaged H357 SP, non-SP, and parent cells as indicated in
text. Human gene-specific, predesigned, and inventoried probes
were purchased from Applied Biosystems, Foster City, CA,
TaqMan QPCR analysis was based on the DDCt relative mRNA
abundance method and normalised to b2-microglobulin expres-
sion. At least two samples per sort parameter were assayed using
an ABI7900 real-time PCR machine (Applied Biosystems).
Subcutaneous tumour model
Six-week-old, male NOD/SCID mice purchased from Harlan
(Bicester, UK) were used for the experiments. All mouse studies
were performed in accordance with British Home Office procedur-
al and ethical guidelines. Animals were housed in pathogen-free
conditions with filtered air, and autoclaved food and water was
available ad libitum. H357 SP(1) and G2(1) cells (both sorted and
passaged once to expand cell numbers) were suspended in sterile
PBS at a concentration of 1 10
7 cellsml
 1. A total of 200ml of the
suspension containing two million cells was injected subcuta-
neously in the left flank with a 29G needle. Tumours were
measured every 3–5 days with callipers, and the volume calculated
as 4/3pr
3, where r is the estimated radius.
Statistics
Student’s t-, Student–Newman–Keuls, and Mann–Whitney sta-
tistical tests were carried out using SigmaStat. Data are expressed
as means±s.e.m. Data not in normal distribution were log
transformed prior to statistical testing.
RESULTS
Squamous cell carcinomas contain an ABC transporter-
and cell density-dependent side population
Several tumours and tumour cell lines maintain a population of
chemotherapeutic and pollutant-resistant cells with characteristics
of stem-like SP cells (Hirschmann-Jax et al, 2004; Kondo et al,
2004). To determine whether SCCs might also contain a
subpopulation of drug-resistant SP cells, four 70% confluent SCC
cell lines were incubated in 5mM Hoechst 33342 dye and analysed
by FACS. Cell confluence was verified by cell cycle analysis
(Figures 1A–C). A characteristic SP fraction was detected in all
four cell lines examined and was stable after 30min dye incubation
as determined by time course analysis (15–135min, SP examined
every 15min; not shown). Overall, SCC-SP abundance varied
between each cell line examined from 0.076% (SCC15) to 0.47%
(H357) (Figures 1D–F and Table 1). All SCC-SP populations were
reserpine sensitive, indicating their dependence on ABC-type
transporter activity (Figures 1G–I).
We next wished to examine whether a cancer’s cellular density
or cell cycle status influenced SCC-SP cell abundance. We therefore
cultured H357 cells to 100% confluence prior to Hoechst dye
incubation (Figure 1J). On average, increased cellular density or
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sreduced proliferation increased the H357 SP cell population from
0.47±0.16 to 4.53±0.61%, or nearly 10-fold (n¼4, Figures 1K
and L).
SCC-SP cells express epithelial stem cell markers
To ascertain whether SCC-SP cells exhibited an enhanced stem
cell-like phenotype, we isolated and serially propagated H357 SCC-
SP cells as indicated in Figure 2A. Using QPCR, we examined the
expression of known epithelial stem cell genes including chon-
droitin sulphate proteoglycan 4 (CSPG4/MCSP; Legg et al, 2003),
tumour suppressor of lung cancer 1 (TSLC1; Morris et al, 2004;
Tumbar et al, 2004), integrin b1 (ITGB1; Jones and Watt, 1993),
and keratin 15 (KRT15; Liu et al, 2003). Serially propagated SCC-
SP cells (SP(3)) expressed significantly more CSPG4/MCSP and
TSLC1 than parent H357 cells but did not express increased levels
of either KRT15 or ITGB1 (Figure 2B). In freshly isolated,
unpassaged SP(1) cells, only TSLC1 expression was significantly
enriched relative to parent cells (data not shown). Altogether, these
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Figure 1 Squamous cell carcinomas contain an SP that varies with cell confluency. Seventy percent confluent SCC4, SCC13, and H357 SCC cells were
stained with propidium iodide staining profiles, highlighting the relative percentage of S-phase cells as an indication of cell confluence (A–C, J). The cells
were incubated in Hoechst 33342 prior to analysis by flow cytometry (D–F). The SP was compared between subconfluent (70%) (F) and confluent (K) cell
populations with reserpine controls (G–I, L).
Table 1 Summary of average SCC SP cell abundance
Cell
line
Average % of
SP s.d.
Minimum/maximum % of
SP
No. of
replicates
H357 0.470 0.160 0.25/0.63 4
SCC4 0.385 0.177 NA 2
SCC13 0.270 0.028 NA 2
SCC15 0.076 0.063 NA 2
NA¼not applicable; SCC¼squamous cell carcinoma; SP¼side population. SP
analysis performed at 70% cell confluence.
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sdata indicate that SCC-SP cells but not parent H357 cells resemble
epithelial stem cells.
Serial SCC-SP cell propagation enhances SP cell abundance
We next wished to examine whether isolated and in vitro expanded
H357 SP cells were capable of repopulating secondary SP and non-
SP populations. Parent H357 cells were therefore labelled with
Hoechst 33342 dye and sorted into two populations termed SP(1)
and G2(1) based on their relative blue/red fluorescence intensity
(Figure 2C, schematic Figure 2A). The G2 grouping reflected each
cell’s relative position in the cell cycle (that is, G2 phase;
Figure 2C). Following in vitro expansion, G2 cells reproduced
both an SP and non-SP cell population in similar proportions to
those of the parent population (0.46%, Figure 2D). In contrast,
SP(1)-sorted cells produced greater numbers of drug-resistant SP
cells relative to both parent and G2 populations (2.98%;
Figure 2D).
On the basis of our observation that SCC-SP cell expansion leads
to an enrichment of drug-resistant cells, we wished to determine
whether further SP cell propagation might continue to increase SP
cell abundance. H357 SP(1) cells were therefore re-sorted into
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Figure 2 Squamous cell carcinomas containing SP cells express stem cell markers and are selectable. (A) Schematic of H357 cell populations isolated
following successive rounds of FACS analysis. (B) Relative mRNA abundance of epithelial stem cell markers chondroitin sulphate proteoglycan 4 (CSPG4/
MCSP), tumour suppressor of lung cancer 1 (TSLC1), integrin b1 (ITGB1), and keratin 15 (KRT15). (C) FACS analysis of Hoechst 33342-stained parental
H357 cells with sorted areas marked SP and G2. (D) FACS analysis of Hoechst 33342-stained cell populations isolated from (C). (E) G2(2) and SP(2) cells
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sSP(2) and G2(2) fractions; SP(2) was additionally expanded and
fractionated into an SP(3) population (see schematic, Figure 2A).
Under these conditions, the ABC-dependent drug-resistant SP
fraction increased dramatically within both SP(2)- and G2(2)-
sorted subpopulations compared to the original parent cells
(Figure 2E). Further SP(2) fractionation to SP(3) increased the
SP fraction to 25.6% of total cells, an increase of approximately 50-
fold from the original parental population (Figure 2E). These
percentages were confirmed with a repeat experiment (data not
shown).
SCC-SP cells express ABCG2 and ABCC1 type ABC
transporters
On the basis of the observation that SCC-SP purification enriched
the relative SP abundance in secondary cultures, we wished to
examine whether SP cells also contained elevated ABC transporter
expression relative to parent and non-SP cells. Results of QPCR
analysis revealed that both parent and freshly sorted SP(1) but not
G2 cells expressed ABCG2(BCRP1) and ABCC1(MRP1) transpor-
ters (Figure 3A). Expression levels were not significantly different
from those of independently isolated haematopoietic SP stem cells
(HSC (SP), Figure 3A). There was additionally no significant
difference in either ABCG2 and ABCC1 expression when serially
propagated SP(3) cells were compared with parent SCCs
(Figure 3B). We were unable to detect ABCB1/MDR1 expression
in any SCC cell lines examined. Overall, these results suggested
that ABC transporter mRNA expression does not directly
determine SP cell abundance.
SCC-SP cells exhibit stem cell-like characteristics in vitro
One of the principal characteristics of epithelial stem cells is
enhanced in vitro clonogenicity and growth. To examine whether
SCC-SP cells exhibit enhanced in vitro proliferation, 1000 parent,
SP(1), and SP(3) cells were cultured for 2, 4, and 8 days. Both SP
cell populations grew significantly more rapidly than parent cells
(Figure 4A). SP(3) cells also exhibited significantly faster growth
rate 8 days postplating than SP(1) cells, indicating a serial
enrichment in SCC-SP proliferative capacity (Figure 4A). The data
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sshown are representative of two proliferation assays performed in
triplicate.
We also examined the clonogenic potential of SCC-SP cells as an
indicator of their individual proliferative capacity. Parent, G2(1),
SP(1), and SP(3) H357 cells were plated in triplicate and cultured at
clonal density for 14 days (Figure 4B). Results revealed significant
increases in large colony formation uniquely within both SP(1) and
SP(3) populations but not G2 cell populations when compared
with parent cells (Figures 4B and C). These findings were especially
evident following serial SP cell propagation (SP(3); Figures 4B and
C).
SCC-SP cells exhibit stem cell-like characteristics in vivo
To test for in vivo tumorigenic potential, we compared the tumour
formation capacity of H357 SCC-SP and non-SP cells. We
subcutaneously injected two million SP(1) cells (n¼6) or two
million G2(1) H357 cells (n¼6) into the flank of NOD/SCID mice
and allowed these to grow for 49 days. In accordance with previous
attempts to grow H357 cells in an in vivo model (Jones et al, 1996;
Janes and Watt, 2004), none of the G2(1) cell grafts produced
tumours (Figures 5A and B). Interestingly, three out of six SCC-SP-
sorted and -engrafted cell populations did produce subcutaneous
tumours with an average volume of 0.038cm
3 (Figures 5A and B).
Human SCC cell contribution to tumours and active cell
proliferation were confirmed by H&E and Ki67 staining (Figures
5C and D). To our knowledge, this is the first demonstration of the
ability of an H357 cell population to produce tumours in vivo,
strongly suggesting that our SCC-SP contains a unique population
of cancer stem-like cells.
Stem-like SCC-SP cells are chemotherapeutic resistant but
sensitised by verapamil
Our observation that SCC-SP cells expressed both ABCG2 and
ABCC1 multidrug transporters and exhibited elevated Hoechst
33342 efflux indicated that these cells likely possessed resistance to
cytotoxic chemotherapeutic drugs including mitoxantrone. To
assess SCC-SP and parent cell mitoxantrone sensitivity, 200 cells
were cultured in the presence of 0, 1, and 10ngml
 1 mitoxantrone
for 3 days followed by 14 days culture in mitoxantrone-free media.
Results indicated that both SP(1) and SP(3) were significantly
more resistant to 10ngml
 1 mitoxantrone treatment and capable
of maintaining large colony formation in comparison with parent
cells (Figure 6A). All cells appeared resistant to 1ngml
 1
mitoxantrone in agreement with previous ABC transporter
expression data (Figure 3A).
To investigate whether the addition of ABC-dependent transport
inhibitors might block mitoxantrone resistance and restore
chemotherapeutic sensitivity, parent and SP(3) cells were cultured
at clonal density in the presence of 1ngml
 1 mitoxantrone alone
or in combination with verapamil for 7 days followed by 7 days in
the absence of both drugs. We found that both parent and SP(3)
cells that previously exhibited full resistance to 1ngml
 1
mitoxantrone were dramatically growth inhibited following
verapamil treatment (Figures 6B and C). These data suggest that
verapamil-dependent ABC transporter inhibition blocks efficient
SCC-SP mitoxantrone efflux, thereby restoring chemotherapeutic
drug sensitivity to this previously resistant and aggressive tumour
stem cell-like population.
DISCUSSION
The present study is the first to identify a Hoechst 33342 effluxing
cell SP in several SCC cell lines that exhibits properties consistent
with cancer stem or stem-like cells. The abundance of this SCC-SP
varied between different SCC cell lines, and appeared highly
dependent on both cellular density and proliferation status. As
expected, SCC-SP cells expressed several previously characterised
multidrug effluxing ABC-type transporters and were resistant to
the chemotherapeutic agent mitoxantrone. SCC-SP cells also
expressed elevated levels of the epithelial stem cell genes MCSP
and TSLC1 relative to parent H357 cells. Importantly, we
demonstrated that SCC-SP cells may be chemosensitised following
the inclusion of ABC transport inhibitors. This finding may
suggest novel approaches to cancer treatment, which could include
the specific targeting of cancer stem cells.
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Figure 5 Squamous cell carcinomas containing SP cells are tumorigenic in vivo.( A, B) Three out of six NOD/SCID mice grew subcutaneous tumours
following injection of two million SCC-SP(1) cells compared with no SCC G2(1) cell-derived tumours (n¼6). (C) H&E confirmed SCC and (D) Ki67
staining demonstrated high cell proliferation.
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confluence dependent has not been previously described. This
observation may partially explain differences reported between
several laboratories studying SP cells and highlights the impor-
tance of considering cell confluence when examining SP cells in
vitro. It is also possible that these cellular density effects might
contribute to the relative ‘stemness’ of cancer cells contained
within an in vivo tumour microenvironment. For example,
infrequently proliferating cells within well-established tumours
might be able to divert increased resources towards maintaining
this chemoresistant or stem cell-like phenotype.
Previous studies of cancers in vitro and primary tumours in vivo
have shown that SP cells are uniquely capable of generating both
SP and non-SP cell fractions. This data have been used to suggest
that SP cells are multipotent ‘cancer stem cells’ (Hirschmann-Jax
et al, 2004; Kondo et al, 2004). In the current study, we find that
serial SCC-SP cell propagation selects for cells that generate an
increased SP cell abundance while maintaining multipotent
differentiation. This is in contrast to non-SP (G2) cell populations,
which could only produce secondary cultures similar to the
original parental H357 cell line. We therefore believe that our SCC-
SP cells uniquely represent a cancer stem or stem-like cell
population.
In addition to stem cell-like properties in SCC-SP cells including
multipotent differentiation and high in vitro/in vivo growth
capacity, we have also now shown that SCC-SP stem cell-like cells
are rendered chemosensitive using simple ABC transport inhibi-
tors including verapamil and reserpine. This finding is significant,
as it has recently been observed that many cancers maintain
subpopulations of stem-like cells, which are chemotherapy
insensitive and uniquely maintain tumour regrowth capabilities
(Bonnet and Dick, 1997; Al-Hajj et al, 2003; Passegue et al, 2003;
Hirschmann-Jax et al, 2004; Singh et al, 2004; Patrawala et al,
2006). Thus, it is increasingly important that cancer treatments
target and eradicate putative cancer stem cells to halt clinical
tumour recurrence. Intriguingly, early combinatorial therapy
experiments demonstrated an effective synergistic therapeutic
effect using verapamil plus mitoxantrone administration in the
treatment of ovarian cancer (Tsuruo et al, 1985; Hendrick et al,
1991). Whether or not this in vivo chemosensitisation occurred via
similar mechanisms to those described in our current study is not
known, although clearly these findings highlight the need for more
research into this potentially combined therapy.
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